Instil Bio, Inc. Loans Payable, Noncurrent
Instil Bio, Inc. (TIL) had Loans Payable, Noncurrent of $85.19 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermLoansPayable · last filed 2026-08-13
- 2026-06-30: Loans Payable, Noncurrent $85.19M.
- 2026-03-31: Loans Payable, Noncurrent $85.00M.
- 2025-12-31: Loans Payable, Noncurrent $84.81M.
- 2025-09-30: Loans Payable, Noncurrent $84.61M.
| Period end | Loans Payable, Noncurrent |
|---|---|
| 2026-06-30 | $85.19M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $85.00M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $84.81M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $84.61M 10-Q · filed 2025-11-13 |
| 2025-06-30 | $84.42M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $84.23M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $84.19M 10-K · filed 2026-03-27 |
| 2024-09-30 | $82.17M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $81.93M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $81.68M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $81.43M 10-K · filed 2025-03-04 |
| 2023-09-30 | $81.18M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $81.52M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $77.06M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $72.35M 10-K · filed 2024-03-21 |
| 2022-09-30 | $62.97M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $49.13M 10-Q · filed 2022-08-12 |
| 2021-12-31 | $0.00 10-K · filed 2023-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| Scilex Holding Co (SCLX) | United States | $0.042B | -0.14 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |